HomeInsightsPE

Kobo Biotech Ltd PE Ratio

Kobo Biotech Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

44.2 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 12, 2024

Image

Kobo Biotech Ltd

NSE: KOBOBIOTECH

PE

-

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Kobo Biotech Ltd is 0 as of 12 Dec 9.00 AM .
  • The P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2019 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Kobo Biotech Ltd is ₹ 3.49 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Kobo Biotech Ltd

No data available

Company Fundamentals for Kobo Biotech Ltd

No data available

Image

Kobo Biotech Ltd

NSE: KOBOBIOTECH

Share Price

₹ 3.49

0.16 (4.80%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Kobo Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Kobo Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 20243.49
10 Dec 20243.33
09 Dec 20243.18
06 Dec 20243.03
05 Dec 20242.89
04 Dec 20242.88
03 Dec 20242.82
02 Dec 20242.85
29 Nov 20242.85
28 Nov 20242.85

SWOT Analysis Of Kobo Biotech Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Kobo Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kobo Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Kobo Biotech Ltd08
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Kobo Biotech Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Kobo Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Kobo Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Kobo Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Kobo Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payout of Kobo Biotech Ltd

No data available

* All values are in %

About Kobo Biotech Ltd

  • Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
  • Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
  • The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

Kobo Biotech Ltd News Hub

News

Kobo Biotech reports standalone net loss of Rs 1.33 crore in the June 2024 quarter

Net Loss of Kobo Biotech reported to Rs 1.33 crore in the quarter ended June 2024 as again...

Read more

2024-08-14 00:00:00

News

Kobo Biotech to discuss results

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 202...

Read more

2024-08-13 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Kobo Biotech Ltd

What is the current PE Ratio of Kobo Biotech Ltd?

The Current PE Ratio of Kobo Biotech Ltd is 0.0 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Kobo Biotech Ltd last year?

The PE Ratio of Kobo Biotech Ltd was 2.28 last year, now the PE ratio is 0.0, showing a year-on-year growth of -100.0%.

What does the PE Ratio of Kobo Biotech Ltd indicate about its stock?

The PE Ratio of Kobo Biotech Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Kobo Biotech Ltd.

What is the PE Ratio Growth of Kobo Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Kobo Biotech Ltd grew by -100.0% whereas, the EPS ratio grew by 5.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions